Product Reports Resources Pricing Login Book a demo

Scorpion Therapeutics

Biotech & Life Sciences · Boston, United States · Founded 2020

Scorpion Therapeutics is a startup operating in the biotechnology sector, specifically focusing on the development of precision oncology treatments. The company's mission is to deliver fast, precise, and lethal strikes against unique cancer drivers. They do this by developing drugs specifically designed to interact with validated cancer targets, optimizing their selectivity and pharmaceutical properties to improve safety and efficacy. Scorpion Therapeutics serves a broad market, including healthcare providers, cancer patients, and pharmaceutical companies. Their clients are those seeking innovative and effective cancer treatments, and their market is global, given the universal nature of cancer. The business model of Scorpion Therapeutics is based on research and development of new drugs, followed by partnerships with larger pharmaceutical companies for distribution and sales. A recent example of this is their partnership with Pierre Fabre, where they prioritized investment in a third asset. This model allows Scorpion Therapeutics to focus on what they do best - developing innovative cancer treatments - while leveraging the resources and distribution networks of established pharmaceutical companies. Scorpion Therapeutics generates revenue through these partnerships, either through upfront payments, milestone payments based on the progress of drug development, or royalties from the sales of the drugs they develop. The company prides itself on its world-class team of experts in various fields, including cancer biology, medicinal chemistry, chemical proteomics, computational chemistry, molecular biophysics, machine learning, and drug development. They also place a high value on their work culture, seeking team members who share their cultural commitments. Keywords: Biotechnology, Precision Oncology, Cancer Treatment, Drug Development, Pharmaceutical Partnerships, Cancer Biology, Medicinal Chemistry, Chemical Proteomics, Computational Chemistry, Molecular Biophysics.

Investors

21 investors on Scorpion Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 16 investors entered at this stage
Atlas Venture
Vida Ventures
Abingworth
Omega Funds
Partners HealthCare
Tavistock Group
EcoR1 Capital
Invus
OrbiMed
Janus Henderson Investors
Nextech Invest
Logos Capital
Wellington Management
Casdin Capital
Boxer Capital
Woodline Partners
Series B+ 5 investors entered at this stage
Lightspeed Venture Partners
Frazier Life Sciences
Willett Advisors
Surveyor Capital
Fidelity Investments

Global footprint

Where Scorpion Therapeutics has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Talent graph

The shape of Scorpion Therapeutics's talent

Dealroom maps Scorpion Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

12 team members profilednamed & role-tagged by Dealroom
16 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Scorpion Therapeutics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Scorpion Therapeutics

An AI-synthesized read of the highest-engagement posts about Scorpion Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Scorpion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.